Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. This is a minor metadata update with no impact on study content or user actions.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now lists a Locations section with Michigan as a location, and the HHS Vulnerability Disclosure and Michigan Locations entries have been removed. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check52 days agoChange DetectedEditorial updates to the Publications section add a note that publications are automatically filled from PubMed and update the page revision label to v3.3.2, replacing the previous PubMed wording and the earlier revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the general operating status notice about government funding and NIH Clinical Center operations. The trial details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedThe new screenshot shows only minor formatting and wording changes with no modifications to the study content or user-facing functions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check102 days agoChange Detected- Added a prominent notice about potential data and processing delays due to funding lapse and updated operating status guidance, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.